myoclonus

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Etomidate, Myoclonus Trial (Remifentanil)

Not yet recruiting
  • Etomidate
  • Myoclonus
  • (no location specified)
Mar 3, 2023

Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders

Recruiting
  • Neurological Regression
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 14, 2023

    Dystonia, Drug Induced Dystonia, Parkinson Disease Trial in Boston (DystoniaNet-based diagnosis of isolated dystonia)

    Recruiting
    • Dystonia
    • +10 more
    • DystoniaNet-based diagnosis of isolated dystonia
    • Boston, Massachusetts
      Massachusetts Eye and Ear Infirmary
    Aug 10, 2022

    Anatomical Differentiation of Epileptic and Non-epileptic

    Completed
    • Myoclonus
    • Evoked Potential
    • Somatosensory evoked potential
    • Mansoura, Dakahlia, Egypt
      Mansoura University Hospital
    Jan 16, 2020

    Myoclonus Trial (Low-dose Dexmedetomidine, High-dose dexmedetomidine, normal saline)

    Unknown status
    • Myoclonus
    • Low-dose Dexmedetomidine
    • +5 more
    • (no location specified)
    Aug 7, 2015

    Myoclonus Trial in Toronto (T2000)

    Terminated
    • Myoclonus
    • Toronto, Ontario, Canada
      Investigator Site
    Dec 19, 2013

    Opsoclonus-myoclonus Syndrome, Opsoclonus, Myoclonus Trial in Springfield (rituximab)

    Completed
    • Opsoclonus-myoclonus Syndrome
    • +3 more
    • Springfield, Illinois
      National Pediatric Myoclonus Center, Department of Neurology, SI
    May 6, 2011

    Movement Disorder, Myoclonus, Nervous System Disease Trial run by the NINDS (Magstim Super Rapid Stimulator)

    Completed
    • Movement Disorder
    • +2 more
    • Magstim Super Rapid Stimulator
    • Bethesda, Maryland
      National Institute of Neurological Disorders and Stroke (NINDS)
    Mar 3, 2008

    Movement Disorders and Other Neurological Diseases

    Completed
    • Movement Disorders
    • +4 more
      • Bethesda, Maryland
        National Institute of Neurological Disorders and Stroke (NINDS)
      Mar 3, 2008